A retrospective cohort study assessing time to insulin initiation among patients with type 2 diabetes mellitus (T2DM) treated with sitagliptin versus sulphonylurea as add-on to metformin.
Phase of Trial: Phase IV
Latest Information Update: 01 Aug 2016
At a glance
- Drugs Sitagliptin (Primary) ; Sulfonylureas (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 01 Aug 2016 New trial record